Table 1.
Hesperidin/ Extract Type |
Hesperidin Levels Tested |
Testing Model |
Main Biological Properties |
Formulation | Potential Applications |
Molecular Pathways/ Other Relevant Properties |
Ref. |
---|---|---|---|---|---|---|---|
Commercial hesperidin |
≈35–70% (w/v) |
In vitro non-cellular assays |
Radical scavenging activity increase in a dose-dependent manner. |
Complex of hesperidin with modified silica (1:1, 1:2 or 2:1 (w/w)) |
Cosmetics/ Cosmeceuticals |
Complex’s antioxidant properties were higher than free hesperidin |
[23] |
Rutaceae fruits extract |
1254.67 μg/mL |
S. epidermidis
E.coli P. acnes |
Radical scavenging activity; Antibacterial activity against S. epidermidis, E. coli and P. acnes. |
Mixed Rutaceae fruits hesperidin-rich ethanolic extract fermented with mushroom mycelium |
Cosmetics/ Cosmeceuticals |
N/A | [35] |
C. unshiu peel extract |
0.25–1% (w/v) |
HDFs cells | MMP-1 expression decreases in a dose-dependent manner; Senescent cells decrease; Collagen biosynthesis increases. |
C. unshiu peel extract fermented with S.commune |
Cosmetics/ Cosmeceuticals |
N/A | [44] |
Citrus sinensis peel bagasse |
Corrosion tests: 100 µg/mL Collagenase assay: 0.08–0.9 mmol/L |
FTS cells | Chelation activity; Collagenase inhibition; Antioxidant activity. |
Nanoemulsion: hesperidin; glycerol; orange oil, poloxamer (Pluronic F127); and water. Nanoemulsion Silky Cream: BisPEG/PPG-16/16 PEG/PPG-16/16 dimethicone; caprylic/capric triglyceride (1%); muru muru butter (1%); cupuaçu butter (1%); andiroba oil (3%); GMS (2%); cetostearyl alcohol (3%); mineral oil (5%); carbopol ULTREZ 10 (0.2%); nano-emulsion (79.8%); triethanolamine (5 drops); vit E-acetate (0.05%); ethylhexylglicerin, phenoxy-ethanol (0.05%) |
Cosmetics/ Cosmeceuticals |
Modulation of MMPs activities |
[63] |
Commercial hesperidin |
50 µM | HaCaT cells exposed to PM2.5 |
Intracellular ROS levels reduction; Apoptotic index reduction; Protein carbonylation and intracellular vacuoles accumulation reversion; Reversion of elevated mitochondrial depolarization; Overall inhibitory effect on PM2.5-induced skin senescence and aging. |
N/A | Cosmetics/ Cosmeceuticals |
Cell viability restoration via PI3K/Akt activation; MAPK activation and autophagy/apoptosis-related protein expression mitigation; Increase in the anti-apoptotic protein Bcl-2 expression; Cell arrest in the G0/G1 phase decrease; β-galactosidase activity and MMP-associated senescence decrease; Oxidation effects decreased by c-Jun and c-Fos protein levels reduction |
[80,81] |
Commercial hesperidin |
0.02% (w/v) |
HaCaT cells | In vitro enhancement of antimicrobial peptide’s mRNA expression. | 0.02% hesperidin; 70% ethanol (w/v) |
Cosmetics/ Cosmeceuticals |
Increase in epidermal differentiation-related protein expression (loricrin and filaggrin); β-glucocerebrosidase and glutathione reductase activity regulation |
[84,85] |
. | 1.03 mmol | In vitro non-cellular assays |
Radical scavenging activity. |
Hesperidin-conjugated pectins: pectin aqueous solution of 8 g (2.5 wt%); hesperidin intermediate (1.03 mmol) solution into a 7.5 wt% sodium hydroxide solution and epichlorohydrin (1.03 mmol) Hesperidin-conjugated pectins Hydrogels: pectin conjugates (5 wt% pectin solution) individually crosslinked with Ca2+, Zn2+, and Fe3+ (0.22 mM ionic solutions) |
Cosmetics/ Cosmeceuticals |
Hesperidin’s ion-binding ability induced the crosslinking of the hydrogel conjugates | [86] |
Commercial hesperidin | 0.05% (w/w) |
In vitro non-cellular assays |
Formulation’s bioadhesive properties improvement. | Biocomposites of cellulose, collagen, and hesperidin (4:1:0.05 (w/w)) |
Cosmetics/ Cosmeceuticals |
N/A | [87] |
HDFs—Human Dermal Fibroblasts; FTS—Full Thickness Skin models; HaCaT—Adult Human Keratinocyte; PM2.5—Particulate Matter with an aerodynamic diameter less than 2.5 µm, studied as an air-pollutant testing model; N/A—Non-Added.